Hepatic neoplasm malignant non-resectable and High blood pressure

Summary:

High blood pressure is found among people with Hepatic neoplasm malignant non-resectable, especially for people who are male, 60+ old.

The study analyzes which people have High blood pressure with Hepatic neoplasm malignant non-resectable. It is created by eHealthMe based on reports of 14 people who have Hepatic neoplasm malignant non-resectable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 28, 2023

14 people who have Hepatic Neoplasm Malignant Non-Resectable and High Blood Pressure are studied.


What is Hepatic neoplasm malignant non-resectable?

Hepatic neoplasm malignant non-resectable (liver cancer non-resectable) is found to be associated with 40 drugs and 8 conditions by eHealthMe.

What is High blood pressure?

High blood pressure is found to be associated with 4,843 drugs and 5,130 conditions by eHealthMe.

Number of High blood pressure in Hepatic neoplasm malignant non-resectable reports submitted per year:

Would you have High blood pressure when you have Hepatic neoplasm malignant non-resectable?

Gender of people who have Hepatic Neoplasm Malignant Non-Resectable and experienced High Blood Pressure *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Hepatic Neoplasm Malignant Non-Resectable and experienced High Blood Pressure *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Insomnia (sleeplessness): 1 person, 7.14%

Common drugs taken by these people *:

  1. Nexavar: 13 people, 92.86%
  2. Urso 250: 2 people, 14.29%
  3. Sorafenib: 1 person, 7.14%
  4. Magnesium Oxide: 1 person, 7.14%
  5. Lumigan: 1 person, 7.14%

Common symptoms for these people *:

  1. Pain Of Skin: 7 people, 50.00%
  2. Indigestion: 7 people, 50.00%
  3. Thyroid Diseases: 7 people, 50.00%
  4. Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 7 people, 50.00%
  5. Skin Disorder (skin disease): 7 people, 50.00%
  6. Nausea (feeling of having an urge to vomit): 7 people, 50.00%
  7. Rashes (redness): 7 people, 50.00%
  8. Diarrhea: 7 people, 50.00%
  9. Dizziness: 7 people, 50.00%
  10. Oropharyngeal Spasm (contraction of oropharynx): 6 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have High blood pressure?

Check whether High blood pressure is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to High blood pressure:

Common drugs associated with High blood pressure:

All the drugs that are associated with High blood pressure:

Common conditions associated with High blood pressure:

All the conditions that are associated with High blood pressure:

How the study uses the data?

The study is based on High blood pressure and Hepatic neoplasm malignant non-resectable, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: